[go: up one dir, main page]

CA2015585A1 - Methode et compose pour le traitement des troubles dermatologiques a mediation par les mastocytes - Google Patents

Methode et compose pour le traitement des troubles dermatologiques a mediation par les mastocytes

Info

Publication number
CA2015585A1
CA2015585A1 CA2015585A CA2015585A CA2015585A1 CA 2015585 A1 CA2015585 A1 CA 2015585A1 CA 2015585 A CA2015585 A CA 2015585A CA 2015585 A CA2015585 A CA 2015585A CA 2015585 A1 CA2015585 A1 CA 2015585A1
Authority
CA
Canada
Prior art keywords
compositions
mast cell
mediated
treatment
dermatologic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015585A
Other languages
English (en)
Other versions
CA2015585C (fr
Inventor
Phillip Frost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Branded Pharmaceutical Products R&D Inc
Original Assignee
Baker Cummins Dermatologicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Dermatologicals Inc filed Critical Baker Cummins Dermatologicals Inc
Publication of CA2015585A1 publication Critical patent/CA2015585A1/fr
Application granted granted Critical
Publication of CA2015585C publication Critical patent/CA2015585C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002015585A 1989-07-10 1990-04-27 Methode et compose pour le traitement des troubles dermatologiques a mediation par les mastocytes Expired - Fee Related CA2015585C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/377,572 US4923875A (en) 1989-07-10 1989-07-10 Method for treatment of mast cell-mediated dermatologic disorders
US377,572 1989-07-10

Publications (2)

Publication Number Publication Date
CA2015585A1 true CA2015585A1 (fr) 1991-01-10
CA2015585C CA2015585C (fr) 1995-10-24

Family

ID=23489660

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015585A Expired - Fee Related CA2015585C (fr) 1989-07-10 1990-04-27 Methode et compose pour le traitement des troubles dermatologiques a mediation par les mastocytes

Country Status (4)

Country Link
US (1) US4923875A (fr)
EP (1) EP0409392A3 (fr)
JP (1) JPH07557B2 (fr)
CA (1) CA2015585C (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994466A (en) * 1990-06-14 1991-02-19 Baker Cummins Pharmaceuticals, Inc. Method of treatment for multiple sclerosis
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
CZ286758B6 (en) * 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
US6506789B2 (en) 1998-06-03 2003-01-14 Shionogi & Co., Ltd. Methods for the treatment of itching comprising administering PGD2 receptor antagonist
ATE295183T1 (de) * 1998-06-03 2005-05-15 Shionogi & Co Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
KR101173509B1 (ko) * 2007-10-05 2012-08-14 도레이 카부시키가이샤 모르피난 유도체 또는 그 약리학적으로 허용되는 산부가염을 유효 성분으로 하는 피부 성상 개선 치료약
US20090093509A1 (en) * 2007-10-08 2009-04-09 Tahir Nazir Methods and Compositions for the Treatment of Pruritus
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
GB0814043D0 (en) * 2008-07-31 2008-09-10 Serentis Ltd The treatment of skin disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416886A (en) * 1981-07-29 1983-11-22 Dermall Limited Method of treating pruritis and composition therefor
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
JPS63501717A (ja) * 1985-10-29 1988-07-14 ベーカー・カミンス・デルマトロジカルス・インコーポレーテッド 抗原誘発性アレルギ−反応を阻止するための方法および組成物
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
EP0375689B1 (fr) * 1987-06-01 1992-08-12 Warner-Lambert Company Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid.
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis

Also Published As

Publication number Publication date
CA2015585C (fr) 1995-10-24
JPH07557B2 (ja) 1995-01-11
EP0409392A3 (en) 1991-09-18
US4923875A (en) 1990-05-08
JPH03204815A (ja) 1991-09-06
EP0409392A2 (fr) 1991-01-23

Similar Documents

Publication Publication Date Title
DE3853558T2 (de) Behandlung von Hyperhidrose und Ichtyosis.
ZA904971B (en) Stable,cosmetically acceptable topical gel formulation and method of treatment for acne
CA2159985A1 (fr) Methodes d'utilisation de l'hesperetine pour le controle du sebum et le traitement de l'acne
CA2063610A1 (fr) Methode pour le traitement du vieillissement de la peau ou de la peau endommagee par les rayons ultra-violets
DE69720053T2 (de) Verminderung des haarwuchses
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
IL99291A (en) Cosmetic preparations
ITMI950575A0 (it) Preparati igienici e cosmetici per prevenire e trattare malattie della pelle nonche' procedimento per il loro ottenimento
EP0396184A3 (fr) Utilisation du kétoconazole et un rétinoide pour le traitement de l acné vulgaire
CA2015585A1 (fr) Methode et compose pour le traitement des troubles dermatologiques a mediation par les mastocytes
EP0352025A3 (fr) Utilisation de nalméfène pour le traitement de la rhinite allergique
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
DE69030923T2 (de) Haarwuchsmittel
CA2355955A1 (fr) Composition eclaircissante pour la peau
GR3026086T3 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
EP0214254A1 (fr) Compositions de melatonine et leurs utilisations.
CA2190377A1 (fr) Compositions de traitement topique des vergetures comprenant de l'acide alpha-hydroxy
JP2002506805A (ja) 保湿組成物
WO1994004184A3 (fr) Procede pour ralentir le vieillissement de la peau
NO920805L (no) Metoder for forhindring og redusering av stoerrelsen av striae distensae-lesjoner
CA2132528A1 (fr) Agent utilise comme anti-irritant
IL136807A0 (en) Topical carbamazepine formulation and methods of use
CA2115045A1 (fr) Composition pour la guerison des dermopathies proliferatives
HK1004889A1 (en) Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases
MX9710475A (es) Utilizacion de al menos un agonista beta-adrenergico como antagonista de sustancia p.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed